Press Releases

Seattle, WA - Jul 7, 2004

Scientist Uncovers Novel Immune System

Scientist at Benaroya Research Institute Uncoveres Novel Immune System

Discovery of a New, Adaptive Immune System Published in Nature

Chris Amemiya, Ph.D., Director of the Genome Resource Center at Benaroya Research Institute (BRI) at Virginia Mason performed experiments for research included in a paper in the July 8 issue of Nature, titled ''Somatic diversification of variable lymphocyte receptors in the agnathan sea lamprey'' along with researchers from University of Alabama and the University of Michigan. The findings explain the discovery of a novel immune system operating in a vertebrate organism called the sea lamprey.

Amemiya used genomics resources and reagents he developed for the sea lamprey (a primitive, jawless vertebrate species) to demonstrate that this organism uses a completely different genetic and molecular toolkit in order to deal with infection. That is, whereas humans use molecules such as antibodies for their "adaptive" immune response, the lamprey uses a completely novel gene system in order to respond to immune challenges. These findings go against dogma concerning the mechanisms involved in adaptive immunity and raise the possibility that other systems may have originated in diverse organisms (such as many invertebrates) to deal with pathogenic challenges.

"The implications from these findings are far-reaching, particularly with regard to our understanding of the genetic underpinnings of a complex biological system. That is, it shows us that in the absence of the cardinal elements needed for an immune system like ours, Mother Nature can improvise with and recruit other molecules in order to mold an alternative and equally effective defense system. The work certainly presents many new possibilities for scientific and biotechnological research." Amemiya said.

"Genomics-based experiments are now driving biological inference in many disparate fields. The finding of a new immune system was entirely unexpected yet it is just the kind of discovery that genomics affords and could open up an entirely new area of study," continued Amemiya. "It is very exciting for investigators like me who have been using non-conventional experimental models for a long time."

Featured BRI Building Exterior 2024

About Benaroya Research Institute

Benaroya Research Institute (BRI) is a world leader in human immune system research. BRI works to advance the science that will predict, prevent, reverse and cure immune system diseases like allergies, asthma, cancer and autoimmune diseases. BRI accelerates discovery through laboratory breakthroughs in immunology that are then translated to clinical therapies. We believe that a breakthrough in one immune system disease can lead to progress against them all, and work tirelessly toward our vision of a healthy immune system for everyone. BRI is a world-renowned independent nonprofit research institute affiliated with Virginia Mason Franciscan Health and based in Seattle.

To learn more, visit benaroyaresearch.org and connect with us on Facebook, Instagram, Threads, LinkedIn, X and YouTube.